Nuclear Medicine and Biology
Volume 37, Issue 3 , Pages 309-315 , April 2010

Efficient automated one-step synthesis of 2-[18F]fluoroethylcholine for clinical imaging: optimized reaction conditions and improved quality controls of different synthetic approaches

Received 9 July 2009 ,Revised 26 November 2009 ,Accepted 22 December 2009.

References 

  1. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells: NMR application of the zero trans method. Anticancer Res. 1996;16:1375–1380
  2. Michel V, Yuan Z, Ramsubir S, Bakovic M. Choline transport for phospholipid synthesis. Exp Biol Med. 2006;231:490–504
  3. Haeffner EW. Studies on choline permeation through the plasma membrane and its incorporation into phosphatidyl choline of Ehrlich-Lettré-ascites tumour cells in vitro. Eur J Biochem. 1975;51:219–228
  4. Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med. 1997;38:842–847
  5. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39:990–995
  6. Kotzerke J, Gschwend JE, Neumaier B. PET for prostate cancer imaging: still a quandary or the ultimate solution?. J Nucl Med. 2002;43:200–202
  7. Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med. 2007;37:420–428
  8. Cimitan M, Bortolus R, Morassut S, et al. [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med. 2006;33:1387–1398
  9. Deves R, Krupka RM. The binding and translocation steps in transport as related to substrate structure: a study of the choline carrier of erythrocytes. Biochim Biophys Acta. 1979;557:469–485
  10. Clary GL, Tsai CF, Guynn RW. Substrate specificity of choline kinase. Arch Biochem Biophys. 1987;254:214–221
  11. DeGrado TR, Coleman RE, Wang S, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001;61:110–117
  12. Hara T, Kosaka N, Hiroichi H. Development of 18F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med. 2001;43:187–199
  13. Pascali G, D'Antonio L, Bovone P, Gerundivi P, August T. Optimization of automated large-scale production of [18F] fluoroethylcholine for PET prostate cancer imaging. doi:10.1016/j.nucmedbio.2009.01.004
  14. Zuhayra M, Alfteimi A, Papp L, et al. Simplified fast and high yielding automated synthesis of [18F]fluoroethylcholine for prostate cancer imaging. Bioorg Med Chem. 2008;16:9121–9126
  15. Bauman A, Piel M, Schirrmacher R, Rösch F. Efficient alkali iodide promoted 18F-fluoroethylations with 2-[18F]fluoroethyl tosylate and 1-bromo-2-[18F]fluoroethane. Tetrahedron Lett. 2003;44:97–99
  16. Piel M, Bauman A, Baum RP, et al. Improved automated synthesis of [18F]fluoroethylcholine as a radiotracer for cancer imaging. Bioorg Med Chem. 2007;15:3171–3175
  17. Wadsak W, Mien LK, Ettlinger DE, et al. 18F fluoroethylations: different strategies for the rapid translation of 11C-methylated radiotracers. Nuc Med Biol. 2007;34:1019–1028
  18. Kwee S, Turner H, Lim J, Wakano C, Coel M. Dimethylaminoethanol reduces [18F]fluoroethylcholine uptake in prostate cancer cells. J Nucl Med. 2006;47(Suppl 1):425P
  19. Iwata R, Pascali C, Bogni A, Furumoto S, Terasaki K, Yanai K. [18F]Fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent: preparation and application to the on-column preparation of [18F]fluorocholine. Appl Radiat Isot. 2002;57:347–352
  20. Kryza D, Tadino V, Filannino MA, Villeret G, Lemoucheux L. Fully automated [18F]fluorocholine synthesis in the TracerLab MXFDG Coincidence synthesizer. Nucl Med Biol. 2008;35:5–260
  21. Mock BH, Winkle W, Vavrek MT. A color spot test for the detection of Kryptofix 2.2.2 in [18F] FDG preparations. Nucl Med Biol. 1997;24:193–195

PII: S0969-8051(09)00299-6

doi: 10.1016/j.nucmedbio.2009.12.009

Nuclear Medicine and Biology
Volume 37, Issue 3 , Pages 309-315 , April 2010

Article Tools

* Image Usage & Resolution